Publications by authors named "Richard Zigeuner"

Claim this Profile
T
Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder Cancer.
Roberto Contieri, Alberto Martini, Irene J Beijert, Laura S Mertens, Anouk E Hentschel, Richard Zigeuner

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?
Irene J Beijert, Anouk E Hentschel, Johannes Bründl, Eva M Compérat, Karin Plass, Richard Zigeuner

Int Urol Nephrol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Charlson-Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder Cancer.
Lukas Scheipner, Hanna Zurl, Julia V Altziebler, Georg P Pichler, Stephanie Schöpfer-Schwab, Richard Zigeuner

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488].
Richard J Sylvester, Oscar Rodríguez, Virginia Hernández, Diana Turturica, Lenka Bauerová, Richard Zigeuner

Eur Urol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery.
Valentina Egger, Georg C Hutterer, Johannes Mischinger, Maximilian Seles, Renate Pichler, Richard Zigeuner

World J Urol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum.
Irene J Beijert, Anouk E Hentschel, Johannes Bründl, Eva M Compérat, Karin Plass, Richard Zigeuner

Eur Urol Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum.
Irene J Beijert, Anouk E Hentschel, Johannes Bründl, Eva M Compérat, Karin Plass, Richard Zigeuner

Eur Urol Focus· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.
Hannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, Michael Stidl, Tobias Niedrist, Richard Zigeuner

Ther Adv Med Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients.
Johannes Mischinger, Helmut Schöllnast, Hanna Zurl, Mark Geyer, Katja Fischereder, Richard Zigeuner

Front Surg· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis.
Franziska Maisel, Maria A Smolle, Stefanie Mollnar, Jakob M Riedl, Dominik A Barth, Richard Zigeuner

Clin Genitourin Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Dominik A Barth, Nazanin Sareban, Andrea K Lindner, Louisa A J Daller, Eva Maria Matzhold, Richard Zigeuner

Urol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Con.
Maximilian Seles, Johannes Mischinger, Richard Zigeuner

Eur Urol Open Sci· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel.
Richard J Sylvester, Oscar Rodríguez, Virginia Hernández, Diana Turturica, Lenka Bauerová, Richard Zigeuner

Eur Urol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study.
Bas W G van Rhijn, Anouk E Hentschel, Johannes Bründl, Eva M Compérat, Virginia Hernández, Richard Zigeuner

Eur Urol Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
Morgan Rouprêt, Marko Babjuk, Maximilian Burger, Otakar Capoun, Daniel Cohen, Richard Zigeuner

Eur Urol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250].
J Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, H Maxim Bruins, Theo M De Reijke, Richard Zigeuner

Eur Urol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer.
Hugh Mostafid, Marko Babjuk, Bernard Bochner, Seth P Lerner, Fred Witjes, Richard Zigeuner

Eur Urol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?
Anouk E Hentschel, Bas W G van Rhijn, Johannes Bründl, Eva M Compérat, Karin Plass, Richard Zigeuner

Urol Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer.
Maximilian Seles, Georg C Hutterer, Johannes Foßelteder, Marek Svoboda, Margit Resel, Richard E Zigeuner

Cancers (Basel)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees.
J Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, H Maxim Bruins, Theo M De Reijke, Richard Zigeuner

Eur Urol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.
Marko Babjuk, Maximilian Burger, Eva M Compérat, Paolo Gontero, A Hugh Mostafid, Richard Zigeuner

Eur Urol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma.
Javier González, Jeffrey J Gaynor, Juan I Martínez-Salamanca, Umberto Capitanio, Derya Tilki, Richard Zigeuner

Eur J Surg Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of early postoperative pain after partial tumour nephrectomy by flank, transabdominal or laparoscopic access.
Boris Hager, Sereina A Herzog, Barbara Hager, Andreas Sandner-Kiesling, Richard Zigeuner

Br J Pain· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study.
Georg C Hutterer, Florian Posch, Lorenz Buser, Richard Zigeuner, Laura Morshäuser

Urol Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of B7-H1, B7-H3 and the stage, size, grade and necrosis (SSIGN) score in metastatic clear cell renal cell carcinoma.
Johannes Mischinger, Eleonore Fröhlich, Sebastian Mannweiler, Claudia Meindl, Markus Absenger-Novak, Richard Zigeuner

Cent European J Urol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis